Following consultation with members of the academic and drug research community, the UK Drug Policy Commission (UKDPC) has identified key gaps in the knowledge base underpinning the drug strategy and the ‘top 10’ are highlighted.
Many of the gaps in knowledge identified at the start of the 1998 strategy have endured, and suggestions are made for some of the causes of this faltering progress. The conclusion is that an overall research strategy and new structures and systems are needed to address the inadequate knowledge base.
